The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids

The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for moderate to severe acute pain. The drug, called Suzetrigine and manufactured by biotech company Vertex Pharmaceuticals,

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.